as of 2026, the FDA has placed injectable GHK-Cu on its Category 2 bulk drug substances list, meaning it cannot be legally compounded for injection due to immunogenicity and impurity concerns
I have very fragile small veins and everyone struggles with them
This is the closest human-trial evidence anywhere in the class, and it was negative
Safe, Sterile, and Easy to Use Each vial is packaged for single use to maintain sterility and efficacy
$439 Typical 46 week program
BioWorld - Monday, August 3, 2026 Breaking News: Best of BioWorld Science: Q2See today's BioWorld Science Home BPC-157 lessens effects of alcohol intoxication and withdrawal To read the full story, subscribe or sign in